KDA Group Inc
XTSX:KDA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.13
0.62
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
KDA Group Inc
KDA Group Inc
Cash & Cash Equivalents
KDA Group Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
KDA Group Inc
XTSX:KDA
|
Cash & Cash Equivalents
CA$1.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
A
|
Andlauer Healthcare Group Inc
TSX:AND
|
Cash & Cash Equivalents
CA$65.9m
|
CAGR 3-Years
30%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Medivolve Inc
OTC:MEDVF
|
Cash & Cash Equivalents
CA$806.2k
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
WELL Health Technologies Corp
TSX:WELL
|
Cash & Cash Equivalents
CA$43.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
|
|
dentalcorp Holdings Ltd
TSX:DNTL
|
Cash & Cash Equivalents
CA$39m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Healwell Al Inc
TSX:AIDX
|
Cash & Cash Equivalents
CA$19.2m
|
CAGR 3-Years
178%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
KDA Group Inc
Glance View
KDA Group, Inc. engages in the provision of solutions and services to pharmaceutical market. The company is headquartered in Thetford Mines, Quebec. The company went IPO on 2009-09-09. The firm operates in three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. The Pharmacy Services segment provides pharmacy staff and placement and consulting services and training. The Pharmaceutical Solutions provides medical communication, technology solutions and health communication. The Technology segment offers software applications, including Virtual Clinics, Virtual Pharmacy, eCommerce for orders of medical cannabis products and Counselling and training Services on medical cannabis products for doctors, pharmacists and patients. Its subsidiaries include Alliance Pharma Operations inc., Elitis Pharma inc., Logistik Pharma inc., CanNorth Medic inc., Groupe Technologique KDA inc., CanNorth Medic International inc. and Pharmapar inc.
See Also
What is KDA Group Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.6m
CAD
Based on the financial report for Apr 30, 2024, KDA Group Inc's Cash & Cash Equivalents amounts to 1.6m CAD.
What is KDA Group Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
1%
Over the last year, the Cash & Cash Equivalents growth was 1 308%. The average annual Cash & Cash Equivalents growth rates for KDA Group Inc have been -10% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
